Understanding generalized pustular psoriasis for improved patient care

Affiliations

¹ Hospital Sultanah Aminah Johor Bahru and Clinical School Johor Bahru, Monash University Malaysia, Subang Jaya, Malaysia.
² St John's Institute of Dermatology, Guys and St Thomas's Hospitals and Kings College London, London, UK.
³ AP-HP Hôpital Saint-Louis, Laboratory of Genetic Diseases, INSERM U1163, Imagine Institute, Université de Paris, Paris, France.

Editorial

Siew Eng Choon et al. Exp Dermatol. 2023 Aug.

. 2023 Aug;32(8):1186-1187.

doi: 10.1111/exd.14883.

¹ Hospital Sultanah Aminah Johor Bahru and Clinical School Johor Bahru, Monash University Malaysia, Subang Jaya, Malaysia.
² St John's Institute of Dermatology, Guys and St Thomas's Hospitals and Kings College London, London, UK.
³ AP-HP Hôpital Saint-Louis, Laboratory of Genetic Diseases, INSERM U1163, Imagine Institute, Université de Paris, Paris, France.

No abstract available

References

1. Capon F. A viewpoint on the genetic determinants of generalised pustular psoriasis. Exp Dermatol. 2023;32:1188-1193.
1. Young KZ, Sarkar MK, Gudjonsson JE. Pathophysiology of generalized pustular psoriasis. Exp Dermatol. 2023;32:1194-1203.
1. Choon SE, Tok PSK, Wong KW, et al. Clinical profile of patients with acute generalized pustular psoriasis with and without IL36RN mutations in multi-ethnic Johor Bahru. Malaysia Exp Dermatol. 2023;32:1263-1271.
1. Hsieh CY, Huang YW, Huang YH, Tsai TF. Deficiency of interleukin-36 receptor antagonist (DITRA): an analysis of 58 Chinese patients in a tertiary hospital in Taiwan. Exp Dermatol. 2023;32:1272-1278.
1. Lim LY, Oon HH. Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis. Exp Dermatol. 2023;32:1246-1252.